In conjunction with the financing, Techcyte gained access to a large dataset of slides and pathology reports from the Mayo Clinic.

The advanced diagnostics space was something of an exception, however, as these stakeholders signaled more openness to the idea, though not without reservations.

The 510(k) clearances were granted to a dozen in vitro diagnostic tests and reagents which used a variety of detection methods and approaches.

Eand arlier this month, the CDC said it was temporarily pausing testing for a range of diseases including rabies, poxviruses, the Epstein-Barr virus.

Last week, readers were most interested in an update from Roche at ESCMID about its tuberculosis testing business.

NEW YORK – Laboratory Corporation of America on Thursday raised its full-year 2026 guidance, projecting revenue of between $14.65 billion and $14.80 billion, which at the midpoint would mean year-over ...

Comprising more than 20 firms and organizations across the infectious disease space, the compact will address issues like test access and data fragmentation.

The blood-based test is designed to help differentiate between schizophrenia and bipolar I disorder in patients with symptoms.

Quest plans to use the net proceeds for general corporate purposes, which may include repaying debt such as $500 million in senior notes maturing on June 1.

The tests use AI-powered algorithms to analyze digital histopathology images, along with patient clinical data.